Comparing Substance Use Consequences between Serotonergic Psychedelics, MDMA, and other Drugs of Abuse Among United States Adults with History of Psychiatric Illness.
Psychedelic-assisted therapy could transform treating psychiatric illness, but harms from exacerbating substance use disorder (SUD) among adults with psychiatric illness using psychedelics have not been studied. A cross-sectional survey in the US was used to test whether Drug Abuse Screening Test sc...
| Publicado en: | International Journal of Mental Health & Addiction Vol. 23; no. 2; pp. 1179 - 1193 |
|---|---|
| Autores principales: | , , , , , , , |
| Formato: | Artículo |
| Publicado: |
Springer Nature
Apr2025
|
| Materias: | |
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ssf&AN=184826067&site=ehost-live header: @attributes: shortDbName: ssf uiTerm: 184826067 longDbName: Social Sciences Full Text (H.W. Wilson) uiTag: AN controlInfo: bkinfo: jinfo: jid: 15571874 46AW jtl: International Journal of Mental Health & Addiction issn: 15571874 maglogo: N pubinfo: dt: Apr2025 vid: 23 iid: 2 pid: 237 pub: Springer Nature artinfo: ui: 184826067 10.1007/s11469-023-01163-2 ppf: 1179 ppct: 14 formats: fmt: – @attributes: type: T – @attributes: type: P size: 1.3MB tig: atl: Comparing Substance Use Consequences between Serotonergic Psychedelics, MDMA, and other Drugs of Abuse Among United States Adults with History of Psychiatric Illness. aug: au: Black, Joshua C. Schow, Nicole Burkett, Hannah L. Pena, Morgan Jewell, Jennifer S. Czizik, Annika Monte, Andrew A. Dart, Richard C. affil: https://ror.org/01fbz6h17 Rocky Mountain Poison & Drug Safety, Denver Health and Hospital Authority, 1391 N. Speer Blvd, #600, M/C 0180, 80204, Denver, CO, USA https://ror.org/04cqn7d42 Department of Emergency Medicine, University of Colorado School of Medicine, Aurora, CO, USA su: Mental depression Medical sciences Bipolar disorder Post-traumatic stress disorder United States history Psilocybin sug: subj: Mental depression Medical sciences Bipolar disorder Post-traumatic stress disorder United States history Psilocybin keyword: LSD MDMA Medical and Health Sciences Clinical Sciences Psychedelics Psychiatric illness US population LSD MDMA Medical and Health Sciences Clinical Sciences Psychedelics Psychiatric illness US population ab: Psychedelic-assisted therapy could transform treating psychiatric illness, but harms from exacerbating substance use disorder (SUD) among adults with psychiatric illness using psychedelics have not been studied. A cross-sectional survey in the US was used to test whether Drug Abuse Screening Test scores (DAST-10, validated instrument predicting SUD) were more severe when psychiatric illnesses (anxiety disorder, major depressive disorder [MDD], post-traumatic stress disorder [PTSD], and bipolar disorder) and serotonergic psychedelic or MDMA use were combined. Any psychedelic use among adults with psychiatric illness history (anxiety: 5.1% [95% CI: 4.7, 5.6]; MDD: 5.1% [4.3, 5.8]; PTSD: 6.9% [5.9, 7.9]; bipolar: 9.2% [8.0, 10.5]) was more prevalent than the general population (2.6% [2.5, 2.8]). Significant increases in scores were associated with psychedelic use independent of other concurrent drug use, but increases were smaller than for opioids or stimulants. Approaches to managing SUD risks with psychedelics should differ from past approaches for other drugs. pubtype: Academic Journal doctype: Article src: R language: English refInfo: copyright: @attributes: flag: N holdings: @attributes: islocal: N |
|---|